Alan J. Russell, Chief Scientific Officer at Edgewise Therapeutics, Inc. (EWTX), sold 39,948 shares at $18.15 ($735K) on 2021-10-08, disclosed to the SEC on 2021-10-08.
Open-market sale of $735k EWTX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.03 | 2,108 | $38K | 5.2% |
| 2 | $18.56 | 13,018 | $242K | 32.9% |
| 3 | $18.56 | 13,018 | $242K | 32.9% |
| 4 | $18.15 | 5,902 | $107K | 14.6% |
| 5 | $18.15 | 5,902 | $107K | 14.6% |
| Total | $18.41 avg | 39,948 |
| $735K |
| 100% |
| Filing → |
| EWTX | SELL | 2025-11-13 | $2.1M | — | Filing → |
| EWTX | SELL | 2025-08-28 | $1.5M | — | Filing → |
| EWTX | SELL | 2025-08-14 | $26K | — | Filing → |